Rolf P.G. van Heeswijk
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosisBy Alexander S. Pym, Andreas H. Diacon, Shen-Jie Tang, Francesca Conradie, Manfred Danilovits, Charoen Chuchottaworn, Irina Vasilyeva, Koen Andries, Nyasha Bakare, Tine De Marez, Myriam Haxaire-Theeuwes, Nacer Lounis, Paul Meyvisch, Ben Van Baelen, Rolf P.G. van Heeswijk and Brian DannemannArticle | Published in 2015 in European Respiratory JournalAlexander S. Pym1Medical Research Council and Kwazulu Research Institute for TB and HIV (K-RITH), Durban, South AfricaAndreas H. Diacon2Division of Medical Physiology and Dept of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for Tuberculosis Research, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South AfricaShen-Jie Tang3Tuberculosis Dept, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, ChinaFrancesca Conradie4Clinical HIV Research Unit, Dept of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaManfred Danilovits5Tartu University Lung Hospital, Tartu, EstoniaCharoen Chuchottaworn6Chest Disease Institute, Ministry of Public Health, Nonthaburi, ThailandIrina Vasilyeva7Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, RussiaKoen Andries8Janssen Infectious Diseases BVBA, Beerse, BelgiumNyasha Bakare9Janssen Research & Development LLC, Titusville, NJ, USATine De Marez9Janssen Research & Development LLC, Titusville, NJ, USAMyriam Haxaire-Theeuwes8Janssen Infectious Diseases BVBA, Beerse, BelgiumNacer Lounis8Janssen Infectious Diseases BVBA, Beerse, BelgiumPaul Meyvisch8Janssen Infectious Diseases BVBA, Beerse, BelgiumBen Van Baelen8Janssen Infectious Diseases BVBA, Beerse, BelgiumRolf P.G. van Heeswijk8Janssen Infectious Diseases BVBA, Beerse, BelgiumBrian Dannemann9Janssen Research & Development LLC, Titusville, NJ, USA
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosisBy Alexander S. Pym, Andreas H. Diacon, Shen-Jie Tang, Francesca Conradie, Manfred Danilovits, Charoen Chuchottaworn, Irina Vasilyeva, Koen Andries, Nyasha Bakare, Tine De Marez, Myriam Haxaire-Theeuwes, Nacer Lounis, Paul Meyvisch, Ben Van Baelen, Rolf P.G. van Heeswijk and Brian DannemannAlexander S. Pym1Medical Research Council and Kwazulu Research Institute for TB and HIV (K-RITH), Durban, South AfricaAndreas H. Diacon2Division of Medical Physiology and Dept of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for Tuberculosis Research, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South AfricaShen-Jie Tang3Tuberculosis Dept, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, ChinaFrancesca Conradie4Clinical HIV Research Unit, Dept of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaManfred Danilovits5Tartu University Lung Hospital, Tartu, EstoniaCharoen Chuchottaworn6Chest Disease Institute, Ministry of Public Health, Nonthaburi, ThailandIrina Vasilyeva7Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, RussiaKoen Andries8Janssen Infectious Diseases BVBA, Beerse, BelgiumNyasha Bakare9Janssen Research & Development LLC, Titusville, NJ, USATine De Marez9Janssen Research & Development LLC, Titusville, NJ, USAMyriam Haxaire-Theeuwes8Janssen Infectious Diseases BVBA, Beerse, BelgiumNacer Lounis8Janssen Infectious Diseases BVBA, Beerse, BelgiumPaul Meyvisch8Janssen Infectious Diseases BVBA, Beerse, BelgiumBen Van Baelen8Janssen Infectious Diseases BVBA, Beerse, BelgiumRolf P.G. van Heeswijk8Janssen Infectious Diseases BVBA, Beerse, BelgiumBrian Dannemann9Janssen Research & Development LLC, Titusville, NJ, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.